Suxibuzone
![]() | |
Systematic (IUPAC) name | |
---|---|
4-[ [4-butyl-3,5-dioxo-1,2-di(phenyl)pyrazolidin-4-yl]methoxy]-4-oxobutanoic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
ATC code | M02AA22 (WHO) QM01AA90 |
PubChem | CID 5362 |
ChemSpider |
5169 ![]() |
UNII |
86TDZ5WP2B ![]() |
KEGG |
D01289 ![]() |
ChEMBL |
CHEMBL1414320 ![]() |
Chemical data | |
Formula | C24H26N2O6 |
Molar mass | 438.47304 g/mol |
| |
| |
![]() ![]() |
Suxibuzone is a drug used for joint and muscular pain. It is a prodrug of the non steroidal anti inflammatory drug phenylbutazone, and is commonly used in horses.
|
|
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.